Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2021-03-16 Annual Report
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2020 (Jan 1, 2020 to Dec 31, 2020). It contains detailed company information, financial data, management discussion, and governance details, which is the standard format for an Annual Report (10-K equivalent in the Korean market). FY 2020
2021-03-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company AnyGen. It outlines the date, time, location, and the agenda items (such as approval of financial statements, articles of incorporation changes, and director compensation). This type of document is a standard proxy solicitation or notice of meeting material sent to shareholders to inform them of upcoming voting items.
2021-03-03 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Anygen Co., Ltd. It details the meeting date, location, agenda items (financial statements, board/auditor remuneration, etc.), and voting procedures (electronic voting). This document is a standard proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their participation/votes. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2021-03-03 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting agenda, such as approval of financial statements, amendments to the articles of incorporation, and director/auditor compensation limits. This document is a formal proxy solicitation statement sent to shareholders to request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-03 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 96% confidence The document is a regulatory filing from a Korean company (Anygen) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). This type of disclosure is a standard regulatory announcement regarding business operations and material contracts. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-02-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (AnyGen) announcing a significant change (over 30%) in revenue or profit structure compared to the previous fiscal year. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report preliminary financial results before the final audit is completed. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's publication, it falls under the category of an Earnings Release (ER). FY 2020
2021-01-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.